Investors further inquired about the progress of the GLP-1 new drug review. Hebei Changshan Biochemical Pharmaceutical responded that the registration inspection has been completed and the approval time cannot be estimated. Directly focus on the earnings
①At today's earnings conference, investors repeatedly inquired about the review progress and approval time of the GLP-1 variety Exenatide injection, and the management team all stated that it is unpredictable; ②The management revealed that the on-site verification and registration inspection of Exenatide injection have been completed, and clinical trials for weight loss indications have not yet been conducted; ③Regarding the performance decline compared to the same quarter of multiple quarters, the management stated that they will accelerate overseas expansion to restore the profitability of the heparin business.
Express News | Contract research organizations surged violently in the final trading session of Hong Kong stocks, with Tigermed soaring nearly 28%, Pharmaron rising over 22%, Joinn Laboratories up more than 17%, Wuxi Apptec up over 16%, and Wuxi Bio up over 14%.
Anxin Life Insurance's third capital increase was approved: The major shareholder New Journey Health subscribed to contribute 0.244 billion yuan, increasing its shareholding ratio to 26.72%.
1. With the rapid development of the business leading to the consumption of capital, Love Life Insurance's solvency has been declining year by year; 2. Since 2022, Love Life Insurance has received shareholding from major shareholders new journey health technology group three times in a row; 3. The convergence of medical into insurance, or insurance into medical, though different paths lead to the same destination, each faces barriers and challenges.
4 million! Star chain users' new journey health technology group milestone is expected to achieve positive free cash flow for the first time.
①Institutions expect that Starlink's revenue will have a year-on-year growth of 80%, and will achieve positive free cash flow for the first time; ②Global satellite operators are actively deploying low-earth orbit communication constellations, with commercial prospects and scarce orbital resources serving as the core driving force for accelerated deployment.
Hong Kong stocks have been soaring for days on heavy volume, haven't jumped on board yet? These directions are still worth paying attention to.
In recent days, the heavy-duty policy bullish continues to catalyze, with large funds actively buying assets in China, and the market's bullish sentiment towards China has been fully ignited. Beneficiary sectors have already risen in advance. Lowering mortgage rates is bullish for consumer spending, with sectors like alcohol, gold, and jewelry taking the lead, while opportunities for biomedical and real estate stocks are worth looking forward to.
Another unreasonable suppression! The U.S. House of Representatives has passed the Biosecurity Act, and wuxi apptec and wuxi bio have quickly responded.
①The U.S. House of Representatives passed the draft of the Biosecurity Act (H.R.8333) with 306 votes in favor and 81 votes against. ②Wuxi Apptec, Wuxi Bio, and other companies strongly opposed it. ③This bill still needs to be voted on by the Senate and the versions passed by both houses need to be reconciled before it can be submitted to the U.S. President for signing into law.